Cogent Biosciences Ownership | Who Owns Cogent Biosciences?

Cogent Biosciences Ownership Summary

Cogent Biosciences is owned by 109.62% institutional investors, 0.16% insiders. Fmr is the largest institutional shareholder, holding 15.04% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cogent Biosciences	109.62%	0.16%	-9.78%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.57M	15.04%	$129.24M
Kynam capital management, lp	9.11M	8.26%	$71.02M
Blackrock funding, inc. /de	8.34M	7.57%	$65.05M
Blackrock	7.29M	7.34%	$61.44M
Tcg crossover management	6.96M	6.32%	$54.32M
Commodore capital lp	6.88M	6.25%	$53.68M
Fairmount funds management	6.23M	5.65%	$48.56M
Vanguard group	6.13M	5.57%	$47.84M
Vr adviser	5.68M	5.16%	$44.34M
Point72 asset management	5.35M	4.85%	$41.71M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	910.87K	6.15%	$7.10M
Tcg crossover management	6.96M	5.31%	$54.32M
Fairmount funds management	6.23M	4.83%	$48.56M
Saturn v capital management	1.50M	4.58%	$11.69M
Kynam capital management, lp	9.11M	4.20%	$71.02M
Commodore capital lp	6.88M	3.93%	$53.68M
Octagon capital advisors lp	2.76M	3.55%	$21.55M
Vr adviser	5.68M	3.04%	$44.34M
New leaf venture partners	250.76K	2.61%	$1.96M
Redmile group	3.55M	1.93%	$27.73M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	16.57M	0.01%	8.25M
Octagon capital advisors lp	2.76M	3.55%	1.46M
Superstring capital management lp	910.87K	6.15%	910.87K
State street	3.92M	0.00%	686.67K
Blackrock	7.29M	0.00%	598.76K

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	5.35M	0.09%	-5.12M
Logos global management lp	-	-	-2.00M
Millennium management	56.51K	0.00%	-1.56M
Sofinnova investments	823.16K	0.47%	-1.44M
Deerfield management company, l.p. (series c)	2.63M	0.39%	-1.11M

New Positions

Holder	Shares	% Assets	Change	Value
Superstring capital management lp	910.87K	6.15%	910.87K	$7.10M
Renaissance	242.93K	0.00%	242.93K	$1.89M
Caption management	112.10K	0.01%	112.10K	$874.38K
Bnp paribas arbitrage, snc	66.78K	0.00%	66.78K	$520.91K
Xtx topco	58.56K	0.04%	58.56K	$456.77K

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Clear point advisors	-1.00
Nelson, van denburg & campbell wealth management group	-16.00
Srs capital advisors	-28.00
Capital performance advisors llp	-37.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	179	9.15%	120,758,047	-0.89%	109	0.90%	96	12.94%	48	4.35%
Sep 30, 2024	161	6.62%	121,811,557	0.36%	110	0.74%	84	6.33%	46	-4.17%
Jun 30, 2024	151	-3.21%	121,368,548	11.09%	122	0.92%	79	-20.20%	48	37.14%
Mar 31, 2024	156	4.70%	109,251,854	20.30%	115	1.05%	99	2.06%	35	16.67%
Dec 31, 2023	149	7.97%	90,815,313	-0.05%	104	0.94%	97	38.57%	30	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.29M	2.89%	-
Vanguard US Total Market Shares ETF	3.09M	2.71%	-
Fidelity Small Cap Growth	2.58M	2.27%	-
iShares Russell 2000 ETF	2.42M	2.13%	-20.95K
Fidelity Select Health Care	2.10M	1.84%	-
SPDR® S&P Biotech ETF	2.05M	1.80%	-22.00K
FIAM Small Cap Core CIT Cl B	1.67M	1.46%	23.34K
FIAM Small Cap Core Composite	1.64M	1.44%	145.08K
Vanguard Institutional Extnd Mkt Idx Tr	1.59M	1.40%	2.70K
Fidelity Advisor Biotechnology I	1.33M	1.17%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 14, 2025	Pinnow Cole	Chief Commercial Officer	Buy	$332.41K
Jun 09, 2023	Fairmount Funds Management LLC	-	Buy	$9.60M
Jun 16, 2022	Fairmount Funds Management LLC		Buy	$9.90M
Apr 26, 2021	Green John L.	Chief Financial Officer	Sell	$157.82K
Apr 26, 2021	Green John L.	Chief Financial Officer	Sell	$157.82K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

COGT Ownership FAQ

Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 109.61%, followed by 0.16% insiders and -9.77% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 68.48%, which Cogent Biosciences exceeds.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Fmr (16.57M shares, 15.04%), Kynam capital management, lp (9.1M shares, 8.26%), and Blackrock funding, inc. /de (8.34M shares, 7.57%). Together, they hold 30.87% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 6.15% of its assets in 910.86K Cogent Biosciences shares, valued at 7.1M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cogent Biosciences shares, with 2.89% of its total shares outstanding invested in 3.29M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools